Vanguard Global Advisers »

Acumen Pharmaceuticals shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Acumen Pharmaceuticals (ABOS) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Acumen Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acumen Pharmaceuticals held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acumen Pharmaceuticals by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $16k 6.7k 2.36

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Acumen Pharmaceuticals

RA Capital Management
Sands Capital Ventures
Alyeska Investment Group
Franklin Resources
ADAR1 Capital Management
FMR
Vanguard Group
Knollwood Investment Advisory
Vanguard Capital Management
Ikarian Capital
Hudson Bay Capital Management
Laurion Capital Management
Pathstone Holdings
SG Americas Securities
Millennium Management

View all funds holding Acumen Pharmaceuticals